PRINCETON, N.J., June 3 /PRNewswire/ -- Celator Pharmaceuticals reported positive results from its CPX-1 Phase 2 clinical trial in patients with advanced colorectal cancer. CPX-1 is a liposomal ...
One innovative entrant into the market of compact, polymer-frame handguns is SCCY Industries (pronounced “sky”) with its CPX-1 and CPX-2 pistols. Both are chambered in the ubiquitous 9 mm Luger ...
PRINCETON, N.J., Sept. 4 /PRNewswire/ -- Celator Pharmaceuticals today announced that the U.S. Food & Drug Administration (FDA) has granted orphan drug designation to CPX-351 (Cytarabine:Daunorubicin) ...
PRINCETON, N.J.--(BUSINESS WIRE)--Celator Pharmaceuticals today announced that the European Commission (EC) has granted orphan drug status to CPX-351, the company's proprietary "liposomal combination ...
SAN DIEGO, California — A novel liposomal formulation of cytarabine and daunorubicin, known as CPX-351 (Vyxeos, Jazz Pharmaceuticals), has again been shown to be superior to a standard version of this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results